
Ambient Clinical Analytics
A software platform designed for data assimilation, communication and analytics.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | $300k | Early VC | |
Total Funding | 000k |
USD | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Ambient Clinical Analytics provides clinical decision support tools for hospitals, focusing on high-acuity environments like the Intensive Care Unit (ICU), Operating Room, and Emergency Department. The company was established in 2014 as a spin-off from the Mayo Clinic, founded by a team of five Mayo Clinic clinicians and CEO Al Berning, a technology entrepreneur with experience leading a company to an IPO. Berning's background includes serving as an Entrepreneur in Residence at Mayo Clinic, where he worked on commercializing a set of AI-based analytics tools for patient care.
The company's core business revolves around licensing its AWARE™ (Ambient Warning and Response Evaluation) platform, which integrates with a hospital's existing Electronic Medical Record (EMR) system. Revenue is generated through software license fees, Software-as-a-Service (SaaS) models, and system integration services. Ambient Clinical Analytics leverages technologies licensed from the Mayo Clinic, incorporating over 1,200 clinically validated rules and algorithms to process patient data in real-time. This enables the platform to deliver actionable insights and alerts to clinicians at the point of care.
The product suite aims to reduce information overload for medical staff by presenting complex patient data through an intuitive, icon-based visualization interface. Key offerings include tools for managing critical care patients and "sniffers" or smart alerts for life-threatening conditions like sepsis and ventilator-induced lung injury. For instance, the Sepsis DART™ (Detection and Response Tool) is designed to help care teams monitor and manage treatment protocols for sepsis. By providing a comprehensive, at-a-glance view of a patient's condition, the software allows clinicians to make faster, more informed decisions, which helps to improve patient outcomes and reduce healthcare costs. The company has secured significant regulatory milestones, including FDA Class II Clearance, CE Marking for sales in the European Economic Area, and ISO 13485:2016 certification for its medical device quality management system.
Keywords: clinical decision support, healthcare analytics, patient monitoring, critical care, ICU technology, EMR integration, sepsis detection, real-time analytics, medical software, Mayo Clinic spin-off, AWARE platform, clinical surveillance, hospital workflow, point-of-care technology, health data visualization, patient safety, Al Berning, operating room tools, emergency department software, medical algorithms, Sepsis DART, FDA cleared medical device